Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Nestler

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
BJU International|April 23, 2020
Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancerAxel Heidenreich, Mark Bludau, Christiane Bruns, et al.
Urologie (Heidelberg, Germany)|September 9, 2025
[New insights from basic research on testicular germ cell tumors and updated tumorigenesis]Margaretha A Skowron, Lisa Schneider, Evangelos Prokakis, et al.
Der Urologe. Ausg. A|January 11, 2021
[Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging]Pia Paffenholz, Tim Nestler, Yasmine Maatoug, et al.
The Journal of Urology|February 8, 2024
Reply by AuthorsTim Nestler, Pia Paffenholz, David Pfister, et al.
BJU International|June 13, 2020
<sup>68</sup> Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancerDavid Pfister, Friederike Haidl, Tim Nestler, et al.
The Journal of Urology|December 12, 2023
Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node DissectionTim Nestler, Pia Paffenholz, David Pfister, et al.
Anticancer Research|May 29, 2023
Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3pElena K Nohl, Jasmin Behring, Ersen Kameri, et al.
Journal of Clinical Laboratory Analysis|May 7, 2021
Non-invasive urine markers for the differentiation between RCCs and oncocytomaMelanie von Brandenstein, Jan Herden, Barbara Köditz, et al.
Tomography (Ann Arbor, Mich.)|August 27, 2025
Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks ApartJustine Schoch, Viola Düring, Michael Wiedmann, et al.
Urologie (Heidelberg, Germany)|December 28, 2023
[Evaluation of the GeSRU-Steps educational video concept (German Society of Residents in Urology e. V.)]Tim Nestler, Emrah Hircin, Carolin Siech, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
BJU International|April 23, 2020
Pelvic exenteration surgery in patients with locally advanced castration-naïve and castration-resistant, symptomatic prostate cancerAxel Heidenreich, Mark Bludau, Christiane Bruns, et al.
Urologie (Heidelberg, Germany)|September 9, 2025
[New insights from basic research on testicular germ cell tumors and updated tumorigenesis]Margaretha A Skowron, Lisa Schneider, Evangelos Prokakis, et al.
Der Urologe. Ausg. A|January 11, 2021
[Using preorchiectomy tumor marker serum concentrations for International Germ Cell Consensus Classification (IGCCCG) risk group assignment results in significant numbers of up- and downstaging]Pia Paffenholz, Tim Nestler, Yasmine Maatoug, et al.
The Journal of Urology|February 8, 2024
Reply by AuthorsTim Nestler, Pia Paffenholz, David Pfister, et al.
BJU International|June 13, 2020
<sup>68</sup> Ga-PSMA-PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancerDavid Pfister, Friederike Haidl, Tim Nestler, et al.
The Journal of Urology|December 12, 2023
Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node DissectionTim Nestler, Pia Paffenholz, David Pfister, et al.
Anticancer Research|May 29, 2023
Improved Analysis of Prostate Cancer: VIM3, ATG7 and P53 Form a Complex and Activate miRNA 371a-3pElena K Nohl, Jasmin Behring, Ersen Kameri, et al.
Journal of Clinical Laboratory Analysis|May 7, 2021
Non-invasive urine markers for the differentiation between RCCs and oncocytomaMelanie von Brandenstein, Jan Herden, Barbara Köditz, et al.
Tomography (Ann Arbor, Mich.)|August 27, 2025
Differences in PI-RADS Classification of Prostate Cancer Based on mpMRI Scans Taken 6 Weeks ApartJustine Schoch, Viola Düring, Michael Wiedmann, et al.
Urologie (Heidelberg, Germany)|December 28, 2023
[Evaluation of the GeSRU-Steps educational video concept (German Society of Residents in Urology e. V.)]Tim Nestler, Emrah Hircin, Carolin Siech, et al.
Pageof 8